Skip to main content

Human Flt-3 Ligand/FLT3L Antibody

R&D Systems, part of Bio-Techne | Catalog # MAB308

Catalog #
Availability
Size / Price
Qty
Loading...
MAB308-100
MAB308-500
MAB308-SP

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Mouse, Primate - Papio cynocephalus (Yellow Baboon)

Applications

Validated:

Western Blot, Neutralization

Cited:

Neutralization, ELISA Development

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 Clone # 40406

Product Specifications

Immunogen

S. frugiperda insect ovarian cell line Sf 21-derived recombinant human Flt‑3 Ligand/FLT3L
Thr27-Pro185
Accession # AAA17999

Specificity

Detects human Flt-3 Ligand/FLT3L in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant mouse Flt-3 Ligand/FLT3L is observed.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Human Flt-3 Ligand/FLT3L Antibody

Cell Proliferation Induced by Flt-3 Ligand/FLT3L and Neutralization by Human Flt-3 Ligand/FLT3L Antibody.

Cell Proliferation Induced by Flt-3 Ligand/FLT3L and Neutralization by Human Flt-3 Ligand/FLT3L Antibody.

Recombinant Human Flt-3 Ligand/FLT3L (Catalog # 308-FK or 308-FKN) stimulates proliferation in the BaF3 mouse pro-B cell line transfected with mouse Flt-3 in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human Flt-3 Ligand/FLT3L (5 ng/mL) is neutralized (green line) by increasing concentrations of Human Flt-3 Ligand/FLT3L Monoclonal Antibody (Catalog # MAB308). The ND50 is typically 0.02-0.06 µg/mL.
Detection of Flt-3 Ligand/FLT3L by Flow Cytometry

Detection of Flt-3 Ligand/FLT3L by Flow Cytometry

Expansion of human DC populations by Alb-Flt3L in humanized mice.NSG mice were irradiated and engrafted with human CD34+ cells according to Taconic’s established protocols. Successful chimerism was confirmed by flow cytometry. Three mice from each donor were generated, allowing for a donor-match control to be in each group (n = 3). Mice were administered Flt3L, Alb-Flt3L (equimolar amounts), or vehicle control every 5 days for a total of 3 doses. Mice were then euthanized, and spleens and bone marrow were harvested and used for immune cell analysis. Representative flow gating and percentages of total DCs gated as CD11c+HLA-DR+ (A and D), cDC1s gated as CD11c+HLA-DR+CD141+ (B and F), cDC2s gated as CD11c+HLA-DR+CD1c+ (B and G), and pDCs gated as CD11c+HLA-DRloCD123+CD303+ (C and E). Representative SPADE analysis of flow cytometry data collected from (H) spleen or (I) bone marrow of mice treated with vehicle, Flt3L, or Alb-Flt3L (equimolar amount). Donor-matched controls are shown. Vehicle was used to set baseline cell populations in each cluster. scRNA-seq data collected from donor-matched spleens of mice treated with vehicle or Alb-Flt3L. UMAP projection of scRNA-seq data from (J) vehicle-treated (naive) or (K) Alb-Flt3L–treated mice. Mono, monocytes. (L) Heatmap showing gene cluster differences in mice treated with Alb-Flt3L compared with control. *P < 0.05; **P < 0.01; ***P < 0.001 by 2-tailed Student’s t test. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37917174), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human Flt-3 Ligand/FLT3L Antibody

Application
Recommended Usage

Western Blot

1 µg/mL
Sample: Recombinant Human Flt‑3 Ligand/FLT3L (Catalog # 308-FK) under non-reducing conditions only.

Neutralization

Measured by its ability to neutralize Flt‑3 Ligand/FLT3L-induced proliferation in the BaF3 mouse pro‑B cell line transfected with mouse Flt‑3. Hannum, C. et al. (1994) Nature 368:643. The Neutralization Dose (ND50) is typically 0.02‑0.06 µg/mL in the presence of 5 ng/mL Recombinant Human Flt‑3 Ligand/FLT3L.

Formulation, Preparation, and Storage

Purification

Protein A or G purified from ascites

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Flt-3 Ligand/FLT3L

Flt-3 Ligand, also known as Flk-2 Ligand, is a transmembrane protein that can be cleaved to release a soluble cytokine. Flt-3 Ligand binds Flt-3 and promotes the growth and differentiation of early hematopoietic progenitor cells.

Long Name

fms-like Tyrosine Kinase 3 Ligand

Alternate Names

FLG3L, Flt3L, FLT3LG

Entrez Gene IDs

2323 (Human); 14256 (Mouse); 102125470 (Cynomolgus Monkey); 493796 (Feline)

Gene Symbol

FLT3LG

UniProt

Additional Flt-3 Ligand/FLT3L Products

Product Documents for Human Flt-3 Ligand/FLT3L Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human Flt-3 Ligand/FLT3L Antibody

For research use only

Loading...
Loading...
Loading...
Loading...
Loading...